OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases (OPHTAI-EVAL)
Diabetic Retinopathy, Diabetic Macular Edema, Age-Related Macular Degeneration
About this trial
This is an interventional screening trial for Diabetic Retinopathy focused on measuring OphtAI, Artificial intelligence, Computer-aided diagnosis, Automated screening, Medical Device, Diabetic patient, Diabetic Retinopathy, Diabetic Macular Edema, Age-Related Macular Degeneration, Age-related Maculopathy, Glaucoma, Evolucare OphtAI
Eligibility Criteria
Doesn't not accept healthy volunteers as diabetic patients are needed, still they may be free of any eye diseases. Inclusion Criteria: The characteristics required for a subject to take part in the research are Male or female over 18, Type 1 or 2 diabetic, Presenting for screening for diabetic retinopathy, Beneficiary of a social security scheme, For whom written consent has been obtained for participation in the protocol. Exclusion Criteria: The following characteristics do not allow the subject to take part in the research: Patient with known DR, more severe than "minimal", including having been treated, Any other condition that, in the opinion of the health professionals, may interfere with their ability to complete the study or may present a significant risk, Presence of social, medical and/or psychological factors that may compromise the patient's adherence to the protocol, Simultaneously participating in another clinical research protocol or having recently participated in another research study for which the exclusion period would not be completed. Patients who participate in this research will not be able to participate in another research at the same time. However, there is no exclusion period at the end of this research for participation in any other study.
Sites / Locations
- Centre Aix VisionRecruiting
- CHU BrestRecruiting
- Centre Ophtalmologique Brétigny EssonneRecruiting
- CH SUD Francilien Corbeil EssonneRecruiting
- Centre d'examens de santé de la CPAM 93Recruiting
- Retinodiab BourgogneRecruiting
- Clinique Honoré Cave
- CHU Nantes
- Retinodiab Franche-Comté
- Diabète OccitanieRecruiting
- CHU ToulouseRecruiting
- OPHDIAT
Arms of the Study
Arm 1
Other
Diabetic patient group assessed for multiple eye diseases
Each patient eye disease status will be assessed by expert readers so to provide ground truth against which algorithms performances will be assessed